MedPath

Effect of General Anesthesia on Enterocyte Damage

Conditions
Non-urgent Surgery
General Anesthesia
Registration Number
NCT02199275
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

During non urgent surgery, general anesthesia might induce enterocyte damage. I-FABP is a performant biomarker of enterocyte damage. We aimed to study whether patient ongoing general anesthesia for non-urgent surgery have an elevation of plasma I-FABP concentration.

Detailed Description

Inclusion criteria

* Indication of non-urgent surgery

* General anesthesia protocol using propofol and remifentanyl

* One half of the patients have a history of ischemic arteriopathy

* One half of the patients have no history of ischemic arteriopathy

Exclusion criteria

* Age \< 18 years old

* Pregnant

Primary objective

Is there a significant elevation of I-FABP between the pre-anesthesic period and 11 minutes after induction of general anesthesia ?

Secondary objectives

1. Is I-FABP elevation higher among patients with history of patent arteriopathy ?

2. Is I-FABP elevation higher among patients presenting with hypotension during anesthesia ?

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
I-FABP elevation after induction of general anesthesia11 minutes

Primary measure of plasma I-FABP before induction of general anesthesia. Second measure of plasma I-FABP concentration 11 minutes after induction of general anesthesia using a protocol of propofol and remifentanyl with monitoring of bispectral index.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

CHRU de Besançon

🇫🇷

Besançon, France

© Copyright 2025. All Rights Reserved by MedPath